Follow
Lewis A. Rolband
Lewis A. Rolband
PhD Student Nanoscale Science
Verified email at uncc.edu
Title
Cited by
Cited by
Year
Challenges in optimizing RNA nanostructures for large-scale production and controlled therapeutic properties
M Chandler, M Panigaj, LA Rolband, KA Afonin
Nanomedicine 15 (13), 1331-1340, 2020
262020
Tuning properties of silver nanoclusters with RNA nanoring assemblies
L Yourston, L Rolband, C West, A Lushnikov, KA Afonin, ...
Nanoscale 12 (30), 16189-16200, 2020
262020
DNA-templated fluorescent silver nanoclusters inhibit bacterial growth while being non-toxic to mammalian cells
L Rolband, L Yourston, M Chandler, D Beasock, L Danai, S Kozlov, ...
Molecules 26 (13), 4045, 2021
222021
Biomotors, viral assembly, and RNA nanobiotechnology: Current achievements and future directions
L Rolband, D Beasock, Y Wang, YG Shu, JD Dinman, T Schlick, Y Zhou, ...
Computational and Structural Biotechnology Journal 20, 6120-6137, 2022
152022
Expanding structural space for immunomodulatory nucleic acid nanoparticles via spatial arrangement of their therapeutic moieties
M Chandler, L Rolband, MB Johnson, D Shi, YI Avila, E Cedrone, ...
Advanced functional materials 32 (43), 2205581, 2022
142022
Small-angle scattering as a structural probe for nucleic acid nanoparticles (NANPs) in a dynamic solution environment
RC Oliver, LA Rolband, AM Hutchinson-Lundy, KA Afonin, JK Krueger
Nanomaterials 9 (5), 681, 2019
132019
Locking and Unlocking Thrombin Function Using Immunoquiescent Nucleic Acid Nanoparticles with Regulated Retention In Vivo
W Ke, M Chandler, E Cedrone, RF Saito, MC Rangel, ...
Nano letters 22 (14), 5961-5972, 2022
92022
Optical, structural, and biological properties of silver nanoclusters formed within the loop of a C-12 hairpin sequence
AK Gupta, N Marshall, L Yourston, L Rolband, D Beasock, L Danai, ...
Nanoscale Advances 5 (13), 3500-3511, 2023
52023
Optical, structural and antibacterial properties of silver nanoparticles and DNA-templated silver nanoclusters
L Danai, LA Rolband, VA Perdomo, E Skelly, T Kim, KA Afonin
Nanomedicine 18 (9), 769-782, 2023
32023
Challenges in optimizing RNA nanostructures for large-scale production and controlled therapeutic properties (vol 15, pg 1331, 2020)
B Chandler, M Panigaj, LA Rolband, KA Afonin
Nanomedicine 15 (19), 1915-1916, 2020
22020
Demonstrating the Synthesis and Antibacterial Properties of Nanostructured Silver
L Rolband, V Godakhindi, JL Vivero-Escoto, KA Afonin
Journal of chemical education 100 (9), 3547-3555, 2023
12023
SAXS for NANPs: Advancing the structural characterization of nucleic acid nanoparticles through small-angle x-ray scattering
L Rolband, K Chopra, M Chandler, L Danai, D Beasock, J Krueger, ...
Journal of Biological Chemistry 299 (3), S75, 2023
12023
Structural Characterization of Nucleic Acid Nanoparticles Using SAXS and SAXS-Driven MD
J Byrnes, K Chopra, LA Rolband, L Danai, S Chodankar, L Yang, ...
RNA Nanostructures: Design, Characterization, and Applications, 65-94, 2023
2023
Aptamer Conjugated RNA/DNA Hybrid Nanostructures Designed for Efficient Regulation of Blood Coagulation
LA Rolband, W Ke, KA Afonin
RNA Nanostructures: Design, Characterization, and Applications, 277-286, 2023
2023
Synthesis of DNA-Templated Silver Nanoclusters and the Characterization of Their Optical Properties and Biological Activity
E Skelly, LA Rolband, D Beasock, KA Afonin
RNA Nanostructures: Design, Characterization, and Applications, 299-307, 2023
2023
Assessing the Biological Activities of DNA-Templated Silver Nanoclusters and Furthering the Characterization of Nucleic Acid Nanoparticles
LA Rolband
The University of North Carolina at Charlotte, 2023
2023
The Natural Versatility of RNA
LA Rolband, OA Shevchenko, CM West, CE Conway, CD Striplin, ...
RNA Nanotechnology and Therapeutics, 73-82, 2022
2022
Light Scattering Techniques for Characterization of NANPs and Their Formulations
LA Rolband, JK Krueger
RNA Nanotechnology and Therapeutics, 181-185, 2022
2022
Poster number 49 submitted by Lewis Rolband
L Rolband, L Yourston, C West, A Lushnikov, K Afonin, ...
The system can't perform the operation now. Try again later.
Articles 1–19